A retrospective study to evaluate the efficacy of combination of Bendamustine, Thalidomide and Dexamethsaone in double relapsed or refractory multiple myeloma.
Phase of Trial: Phase IV
Latest Information Update: 30 Nov 2015
At a glance
- Drugs Bendamustine (Primary) ; Dexamethasone; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 30 Nov 2015 New trial record